ICON PLC (ICLR)

Currency in USD
171.82
+6.49(+3.93%)
Closed·
171.98+0.16(+0.09%)
·
ICLR Scorecard
Full Analysis
Management has been aggressively buying back shares
ICLR is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
163.42172.99
52 wk Range
125.10231.89
Key Statistics
Prev. Close
165.33
Open
163.42
Day's Range
163.42-172.99
52 wk Range
125.1-231.89
Volume
975.04K
Average Volume (3m)
1.03M
1-Year Change
-22.04%
Book Value / Share
120.03
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
ICLR Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
208.27
Upside
+21.21%
Members' Sentiments
Bearish
Bullish
ProTips
High shareholder yield

ICON PLC News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Technical Indicators
Strong Buy
Moving Averages
Neutral

ICON PLC Company Profile

ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies. It also provides clinical development services, including all phases of development, peri and post approval, data solutions, and site and patient access services; clinical trial management, consulting, and contract staffing services; and commercial services comprising clinical development strategy, planning and trial design, full study execution, and post-market commercialization. In addition, the company offers laboratory services, including bionanalytical, biomarker, vaccine, good manufacturing practice, and central laboratory services, as well as full-service and functional service partnerships to customers. Further, the company provides adaptive trials, cardiac safety solutions, clinical and scientific operations, consulting and advisory, commercial positioning, decentralized and hybrid clinical trials, early clinical, laboratories, language services, medical imaging, real world intelligence, site and patient, and strategic solutions. It serves pharmaceutical, biotechnology, and medical device industries, as well as government and public health organizations. ICON Public Limited Company was incorporated in 1989 and is headquartered in Dublin, Ireland.

ICON PLC SWOT Analysis


CRO Market Dynamics
Explore ICON's navigation of industry challenges, including bookings volatility and demand uncertainties in the competitive CRO landscape
Financial Resilience
Delve into ICON's solid financial health, with EPS forecasts of $13.40 (FY1) and $14.06 (FY2), despite recent market pressures
Strategic Positioning
Learn how ICON leverages proprietary technology and global scale to capture high-quality opportunities in a shifting pharmaceutical landscape
Valuation Insights
Analysts set price targets ranging from $155 to $263, suggesting potential for value realization as transient headwinds subside
Read full SWOT analysis

ICON PLC Earnings Call Summary for Q3/2025

  • ICON PLC beats Q3 2025 expectations with EPS of $3.31 and revenue of $2.043 billion, up 0.6% year-over-year
  • Stock declines despite strong earnings; company maintains 'GREAT' financial health score of 3.18/5
  • Focus on AI technologies and biotech market penetration amid regulatory improvements
  • Full-year 2025 revenue guidance set at $8.05-$8.1 billion; adjusted EPS expected between $13-$13.20
  • Elevated cancellations remain a challenge; normalization anticipated in 2026
Last Updated: 23/10/2025, 14:38
Read Full Transcript

Compare ICLR to Peers and Sector

Metrics to compare
ICLR
Peers
Sector
Relationship
P/E Ratio
21.9x28.5x−0.6x
PEG Ratio
−1.30−0.120.00
Price/Book
1.4x2.3x2.6x
Price / LTM Sales
1.6x2.5x3.4x
Upside (Analyst Target)
28.0%10.0%39.1%
Fair Value Upside
Unlock19.5%5.4%Unlock

Analyst Ratings

11 Buy
6 Hold
0 Sell
Ratings:
17 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 208.27
(+21.21% Upside)

Earnings

Latest Release
Oct 22, 2025
EPS / Forecast
3.31 / 3.30
Revenue / Forecast
2.04B / 1.98B
EPS Revisions
Last 90 days

ICLR Income Statement

People Also Watch

266.80
FDS
-0.83%
66.69
FI
+2.30%
186.68
ALAB
+10.10%
317.20
ELV
-1.48%
170.54
LULU
+1.50%

FAQ

What Stock Exchange Does ICON PLC Trade On?

ICON PLC is listed and trades on the Nasdaq Stock Exchange stock exchange.

What Is the Stock Symbol for ICON PLC?

The stock symbol for ICON PLC is "ICLR."

What Is the ICON PLC Market Cap?

As of today, ICON PLC market cap is 13.12B.

What Is ICON PLC's Earnings Per Share (TTM)?

The ICON PLC EPS (TTM) is 7.47.

When Is the Next ICON PLC Earnings Date?

ICON PLC will release its next earnings report on 24 Feb 2026.

From a Technical Analysis Perspective, Is ICLR a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has ICON PLC Stock Split?

ICON PLC has split 2 times.

How Many Employees Does ICON PLC Have?

ICON PLC has 39800 employees.

What is the current trading status of ICON PLC (ICLR)?

As of 02 Nov 2025, ICON PLC (ICLR) is trading at a price of 171.82, with a previous close of 165.33. The stock has fluctuated within a day range of 163.42 to 172.99, while its 52-week range spans from 125.10 to 231.89.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.